Bio-Techne, Woburn, MA, United States.
Front Immunol. 2022 Mar 7;13:803380. doi: 10.3389/fimmu.2022.803380. eCollection 2022.
The versatility of natural killer cells has ignited growing interest in their therapeutic use for cancer and other immunotherapy treatments. However, NK cells compose a small portion of peripheral blood mononuclear cells (5%-20% of PBMCs) and clinical doses require billions of cells. Manufacturing suitable doses of NK cells remains a major challenge for NK immunotherapy. The current standard for expanding NK cells relies on feeder cells and fetal bovine serum to achieve large expansion, but both encounter regulatory concerns. We developed NK Cloudz, a dissolvable polymer-based microsphere platform, as an alternative to a feeder cell approach to expand NK cells. We demonstrated that a combination of NK Cloudz, a G-Rex6M culture vessel, and GMP Human Platelet Lysate expanded NK cells 387 ± 100-fold in 10 days from a PBMC starting population. The NK purity, viability, and cytotoxicity were similar to both a feeder cell protocol and an FBS-based protocol. Additionally, we found no significant differences between FBS and GMP Human Platelet Lysate and concluded that platelet lysate is a good xeno-free alternative to FBS for NK expansion. Overall, we demonstrated a feeder-cell-free and FBS-free protocol that leverages NK Cloudz as a promising step toward a commercial GMP manufacturing method to expand NK cells for therapeutic use.
自然杀伤细胞的多功能性激发了人们对其在癌症和其他免疫疗法治疗中的治疗用途的浓厚兴趣。然而,NK 细胞在周围血单核细胞(PBMC)中仅占很小一部分(占 PBMC 的 5%-20%),而临床剂量需要数十亿个细胞。制造合适剂量的 NK 细胞仍然是 NK 免疫疗法的主要挑战。目前扩增 NK 细胞的标准依赖于饲养细胞和胎牛血清来实现大规模扩增,但这两者都存在监管方面的问题。我们开发了 NK Cloudz,这是一种基于可溶解聚合物的微球平台,可作为替代饲养细胞的方法来扩增 NK 细胞。我们证明,NK Cloudz 与 G-Rex6M 培养容器和 GMP 人血小板裂解物的组合可在 10 天内将 PBMC 起始群体扩增 387 ± 100 倍。NK 细胞的纯度、活力和细胞毒性与饲养细胞方案和基于 FBS 的方案相似。此外,我们发现 FBS 和 GMP 人血小板裂解物之间没有显著差异,并得出结论,血小板裂解物是替代 FBS 用于 NK 扩增的无动物源替代品。总体而言,我们展示了一种无饲养细胞和无 FBS 的方案,该方案利用 NK Cloudz 作为一种有前途的方法,朝着用于治疗用途的商业 GMP 制造方法来扩大 NK 细胞。